Munich / Münster, Germany – October 16th, 2025 – athagoras is proud to announce the acquisition of DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH, a well-established German consultancy specialising in Regulatory Affairs (RA) and Pharmacovigilance (PV). This move marks another important milestone in strengthening Athagoras’ expertise and expanding its presence in Germany, a key market in the European Life Sciences landscape.
By integrating DiaMed into the group, athagoras builds on its existing capabilities in RA and PV, further deepening scientific know-how, increasing local capacity, and ensuring scalable, high-quality support for clients across the product lifecycle. DiaMed’s team brings decades of hands-on experience in regulatory strategy, compliance, and drug safety, which will complement and enhance athagoras’ current operations in Germany, including those of CSO Pharma, and S-Cubed, member of the PV cluster.
“DiaMed is a highly valuable addition to our group, further strengthening our Regulatory Affairs and Pharmacovigilance cluster,” said Giuseppe Pileggi, CEO of athagoras. “Their proven expertise and strong client relationships in Germany align well with our commitment to operational excellence and local-market understanding. Alongside S-Cubed and CSO Pharma, we are expanding a European platform that delivers integrated, tech-enabled Life Sciences services with a scientific backbone.”
Founded in 1992 by Dr. Johannes Kremer, DiaMed has long been a trusted partner for pharmaceutical companies seeking reliable guidance in both regulatory and post-marketing activities.
“Joining athagoras marks an exciting new chapter for DiaMed,” said Dr. Johannes Kremer, Founder and CEO of DiaMed. “We’re proud to bring our practical experience and customer commitment into a wider European network. Together with our new colleagues, we’ll enhance what we do best, supporting clients with tailor-made solutions that ensure compliance and safety.”
This acquisition reinforces athagoras’ commitment to supporting the development of safe and effective medicines while maintaining close proximity to local and regional clients. With strong teams already operating in Germany, the UK, and across Europe, athagoras connects specialist expertise with data-driven processes, creating a platform that empowers clients to navigate regulatory complexity with confidence.
